Wilmington Trust’s Zimmer Biomet ZBH Stock Holding History

Wilmington Trust’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$1.82M	Sell	18,064 -191	-1%	-$18.6K	0.03%	282
2014 Q1	$1.68M	Sell	18,255 -118	-0.6%	-$10.9K	0.03%	280
2013 Q4	$1.66M	Sell	18,373 -280	-2%	-$24.2K	0.03%	281
2013 Q3	$1.49M	Sell	18,653 -383	-2%	-$30.1K	0.03%	275
2013 Q2	$1.39M	Buy	+19,036	New	+$1.42M	0.03%	269

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

IIS

Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wilmington Trust's ZBH Position: Q2 2014 in Review

Wilmington Trust reduced its Zimmer Biomet (ZBH) stake by 1% in Q2 2014, selling an estimated $18.6K and leaving 18,064 shares worth $1.82M. The position accounts for 0.03% of the portfolio, ranked #282.

Wilmington Trust first reported a position in ZBH in Q2 2013 and has held it in 5 quarters since. 707 funds tracked by Wall St. Rank hold ZBH as of Q2 2014.

Wilmington Trust held 18,064 shares of Zimmer Biomet worth $1.82M as of Q2 2014.
Wilmington Trust sold 191 Zimmer Biomet shares in Q2 2014, an estimated $18.6K.
Zimmer Biomet made up 0.03% of Wilmington Trust's portfolio in Q2 2014, its #282 holding.
Wilmington Trust first reported a position in Zimmer Biomet in Q2 2013 and has held it in 5 quarters since.
707 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.